Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Forte Biosciences, Inc. - Common Stock
(NQ:
FBRX
)
10.91
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 4, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Forte Biosciences, Inc. - Common Stock
< Previous
1
2
3
4
5
Next >
Forte Biosciences, Inc. to Present at Upcoming Healthcare Conferences
November 03, 2025
From
Forte Biosciences, Inc.
Via
Business Wire
Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules
October 03, 2025
From
Forte Biosciences, Inc.
Via
Business Wire
Forte Biosciences, Inc. Announces Presentation of FB102 Celiac Disease Trial at Tampere Celiac Disease Symposium
September 15, 2025
From
Forte Biosciences, Inc.
Via
Business Wire
Forte Biosciences Tops Q2 Loss Forecasts
August 14, 2025
Via
The Motley Fool
Topics
Intellectual Property
Forte Biosciences, Inc. Announces Results and Provides Update
August 14, 2025
From
Forte Biosciences, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's Intraday Session
June 25, 2025
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
June 25, 2025
Via
Benzinga
Forte Biosciences Announces Pricing of $75 Million Public Offering
June 25, 2025
From
Forte Biosciences, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's After-Market Session
June 24, 2025
Via
Benzinga
Forte Biosciences Announces Proposed Public Offering
June 24, 2025
From
Forte Biosciences, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Monday's Pre-Market Session
June 23, 2025
Via
Benzinga
Forte Biosciences Announces Positive Data in FB102 Celiac Disease Phase 1B Study
June 23, 2025
From
Forte Biosciences, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's Intraday Session
May 27, 2025
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
May 19, 2025
Via
Benzinga
Why Novavax Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
May 19, 2025
Via
Benzinga
Forte Biosciences, Inc. Announces Results and Provides Update
May 15, 2025
From
Forte Biosciences, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
April 23, 2025
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
April 07, 2025
Via
Benzinga
Forte Biosciences, Inc. Announces Results and Provides Clinical Update
March 31, 2025
From
Forte Biosciences, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's Intraday Session
March 25, 2025
Via
Benzinga
Forte Biosciences, Inc. to Present at Upcoming Investor Meetings
February 03, 2025
From
Forte Biosciences, Inc.
Via
Business Wire
Why Forte Biosciences (FBRX) Stock Is Trading Lower
December 16, 2024
Forte Biosciences shares are trading lower by 13.6% Monday afternoon. The company announced plans for the periodic resale of up to 9.5 million common stock shares by selling stockholders.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
December 04, 2024
Via
Benzinga
Forte Biosciences to Host R&D Day December 3, 2024
November 25, 2024
From
Forte Biosciences, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
November 20, 2024
Via
Benzinga
Forte Biosciences Shares Are Soaring Today: What's Going On?
November 20, 2024
Forte Biosciences Inc. (NASDAQ: FBRX) shares are trading higher Wednesday. The company announced a $53 million private placement to fund the development of its autoimmune-focused drug candidate, FB102....
Via
Benzinga
Crude Oil Moves Lower; Williams-Sonoma Shares Gain After Q3 Results
November 20, 2024
Via
Benzinga
Nasdaq Tumbles Over 100 Points; TJX Earnings Top Views
November 20, 2024
Via
Benzinga
US Stocks Mostly Lower; Target Posts Downbeat Earnings
November 20, 2024
Via
Benzinga
Forte Biosciences, Inc. Announces Oversubscribed $53 Million Private Placement From Leading Healthcare Institutional Investors to Advance FB102 Across Autoimmune Indications
November 20, 2024
From
Forte Biosciences, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today